AP Biosciences, Inc. (TPEX:6945)
Taiwan · Delayed Price · Currency is TWD 118.00
+4.00 (3.51%)
Nov 13, 2026, 1:30 PM CST
AP Biosciences Market Cap
AP Biosciences has a market cap or net worth of 11.51 billion as of November 13, 2026. It is the 16,867th most valuable company in the world and the 622nd biggest in Taiwan. Its market cap has increased by 18.61% in one year.
Market Cap
11.51B
Enterprise Value
9.58B
Revenue
n/a
Global Rank
Country Rank
#622 Taiwan
PE Ratio
n/a
ChartMarket Cap Chart
Since July 14, 2023, AP Biosciences's market cap has increased from 5.10B to 11.51B, an increase of 125.85%. That is a compound annual growth rate of 27.65%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2026 | 11.51B | -24.88% |
| Dec 31, 2025 | 15.32B | 262.77% |
| Dec 31, 2024 | 4.22B | 39.97% |
| Dec 29, 2023 | 3.02B | -40.79% |
| Jul 14, 2023 | 5.10B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| TaiMed Biologics | 17.57B |
| EirGenix | 16.61B |
| Gongwin Biopharm Holdings | 16.59B |
| CHO Pharma | 16.41B |
| Medigen Vaccine Biologics | 15.40B |
| Ever Supreme Bio Technology | 14.91B |
| Lumosa Therapeutics | 14.25B |
| ACRO Biomedical | 13.94B |